Rhode Island’s Medicaid program is contemplating an end to coverage for GLP-1 drugs prescribed for weight loss. The proposal ...
Italy's main medicines regulator gave the go-ahead on Tuesday for human clinical trials on raloxifene, a generic osteoporosis drug that researchers hope may also help reduce COVID-19 symptoms and make ...
Medicare Part D drug plans are expected to come with higher premiums and out-of-pocket deductibles, and some plans may pull ...
CheapInsurance.com reports that a new $2,000 out-of-pocket cap under Medicare Part D will save millions, but challenges ...
There couldn’t be a more pressing or galvanizing topic for Americans than the high cost of prescription drugs. And after ...
The final guidance for the 2028 cycle of the Medicare drug price negotiation reflects CMS’s continued effort to balance ...
Statins are best known for lowering LDL, the “bad” kind of cholesterol that builds up in your arteries over time and increases your risk for heart attack and stroke. Statins act as a sort of gardener ...
3don MSNOpinion
The second phase of the trade war could be sector tariffs
Countries that did not run bilateral trade surpluses with the U.S. are now subject to a universal 10 percent rate. In ...
The market breathed a sigh of relief last week when Pfizer struck a deal with President Donald Trump. Investors took it as ...
Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...
UC Berkeley emeritus professor John Clarke, UC Santa Barbara professor Michel H. Devoret and UC Santa Barbara professor John ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback